AATD predisposes primarily to chronic obstructive pulmonary disease because of excess unopposed neutrophil elastase activity, and to liver cirrhosis due to a toxic gain‐of‐function of alpha‐1 antitrypsin (AAT) in the liver. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.